Article Details
Retrieved on: 2022-01-20 13:45:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BOSTON, Jan. 20, 2022 /PRNewswire/ -- Oxeia Biopharmaceuticals, a clinical stage biotech company conducting Phase 2 clinical trials of OXE103 for ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here